Drug Delivery
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of research on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels.
It accepts research on the following topics:
All drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery;
All modes of drug entry, such as controlled release systems;
Microcapsules, liposomes, vesicles, and macromolecular conjugates;
Antibody targeting;
Protein/peptide delivery;
DNA, oligonucleotide and siRNA delivery.
It accepts research on the following topics:
All drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery;
All modes of drug entry, such as controlled release systems;
Microcapsules, liposomes, vesicles, and macromolecular conjugates;
Antibody targeting;
Protein/peptide delivery;
DNA, oligonucleotide and siRNA delivery.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Liposomal Drug Delivery: Three Decades from the First Liposomal Drug Delivery Medicine in Clinical Use (Deadline: 31 October 2023)
- Nano-Drug Delivery for Cancer Treatment (Deadline: 30 November 2023)
- Feature Reviews in Anticancer Drug Delivery Systems (Deadline: 30 November 2023)
- State-of-the-Art Drug Delivery in the UK (Deadline: 30 November 2023)
- Approaches to Modulate the Effects of Drug Transporters for Drug Delivery and Development (Deadline: 30 November 2023)
- Targeted Drug Delivery in Immune Diseases (Deadline: 15 December 2023)
- The Use of Nanomedicines for Site-Specific Delivery and Controlled Release (Deadline: 15 December 2023)
- Extracellular Vesicles in Drug Delivery System (Deadline: 31 December 2023)
- Advanced Research in Drug Delivery across the Blood–Brain Barrier (BBB) (Deadline: 31 December 2023)
- Novel Drug Delivery Systems: Design, Evaluation and Application (Deadline: 31 December 2023)
- State-of-the-Art Drug Delivery in Europe (Deadline: 31 January 2024)
